

Chromatin structure provides a foundational roadmap for gene expression, cellular identity, and disease development. To fully realize the potential of chromatin research for human health, scientists need dynamic technologies that can adapt to their needs and enable new paths of discovery.
With decades of experience and active collaborations in epigenetics research (see co-authored publications), EpiCypher uniquely understands the challenges facing this field – and how to solve them. Our scientists are leading the development of innovative products and high-throughput services that are backed by a rigorous scientific approach, validated protocols, and quantitative assay controls.
EpiCypher works with groups spanning academia, industry, and clinical trials. These experiences inspire us to push technological boundaries, making chromatin more accessible to answer nature’s most complex and enduring questions. As your research partner, our team can help take your science to the next level.
Request InfoEpiCypher is dedicated to creating novel platforms that support innovative chromatin research. We are constantly expanding our product lines to provide the latest in quantitative chromatin technology.
Versatile chromatin mapping assays with improved sensitivity, throughput, and costs vs. ChIP-seq.
Learn MoreSister technology to CUT&RUN, developed for specialized epigenomic applications.
Learn MoreControl for all aspects of your chromatin mapping experiment using our unique spike-in technology.
Learn MoreEpiCypher’s CUTANA™ CUT&RUN Services provide unique access to our genomic expertise, enabling diverse applications across biomedical research and drug development.
Learn MoreEpiDyne® enables direct detection of chromatin remodeling activity, and is ideal for HTS and inhibitor profiling. EpiDyne services accelerate assay development and generate robust results.
Learn MoredCypher™ assay services rapidly interrogate chromatin reader binding against a collection of modified histone peptides or nucleosomes, revealing novel mechanisms in chromatin biology.
Learn MoreNucleosomes are the preferred target of chromatin interacting proteins, and are optimal substrates for epigenetics research. To address this need, EpiCypher provides custom nucleosome development.
Learn MoreCheck in for the latest in EpiCypher technology, chromatin research, and conference news!
Ellen N. Weinzapfel, PhD
Hannah Devens, PhD and Ellen N. Weinzapfel, PhD
Hannah Devens, PhD
Create an account with us and you'll be able to: